📰 Andreaf Wainer News
Page 19 - Andreaf Wainer News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Andreaf Wainer. Real-time updates on events, politics, business and more.
March 31, 2024
Synergy Asset Management LLC increased its stake in Abbott Laboratories (NYSE:ABT – Free Report) by 21.1% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 30,662 shares of the healthcare product maker’s stock after purchasing an additional 5,349 shares during the period. […]
March 31, 2024
Bank Hapoalim BM acquired a new stake in shares of Abbott Laboratories (NYSE:ABT – Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund acquired 10,447 shares of the healthcare product maker’s stock, valued at approximately $1,150,000. Several other hedge funds and other […]
March 31, 2024
Bank Hapoalim BM purchased a new stake in shares of Abbott Laboratories (NYSE:ABT – Free Report) in the 4th quarter, according to the company in its most recent disclosure with the SEC. The firm purchased 10,447 shares of the healthcare product maker’s stock, valued at approximately $1,150,000. A number of other hedge funds and other […]
March 29, 2024
MBL Wealth LLC increased its stake in Abbott Laboratories (NYSE:ABT – Free Report) by 6.7% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,504 shares of the healthcare product maker’s stock after purchasing an additional 157 shares during the period. MBL Wealth […]
March 29, 2024
Chilton Capital Management LLC lifted its position in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 1.1% in the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 10,926 shares of the healthcare product maker’s stock after buying an additional 119 shares during the quarter. Chilton Capital Management […]
March 28, 2024
West Oak Capital LLC trimmed its stake in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 3.2% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 22,763 shares of the healthcare product maker’s stock after selling 745 shares during the period. Abbott Laboratories makes […]
March 28, 2024
West Oak Capital LLC decreased its holdings in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 3.2% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 22,763 shares of the healthcare product maker’s stock after selling 745 shares during […]
March 28, 2024
Steel Grove Capital Advisors LLC purchased a new stake in Abbott Laboratories (NYSE:ABT – Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 2,029 shares of the healthcare product maker’s stock, valued at approximately $223,000. Other hedge […]
March 28, 2024
Steel Grove Capital Advisors LLC acquired a new stake in Abbott Laboratories (NYSE:ABT – Free Report) during the 4th quarter, Holdings Channel reports. The institutional investor acquired 2,029 shares of the healthcare product maker’s stock, valued at approximately $223,000. A number of other hedge funds and other institutional investors have also bought and sold shares […]
March 27, 2024
Smith Anglin Financial LLC reduced its position in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 27.4% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 3,513 shares of the healthcare product maker’s stock after selling 1,329 shares during […]